HEADER SUGAR BINDING PROTEIN 15-MAY-05 1X50 TITLE SOLUTION STRUCTURE OF THE C-TERMINAL GAL-BIND LECTIN DOMAIN FROM HUMAN TITLE 2 GALECTIN-4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAL-BINDING_LECTIN DOMAIN; COMPND 5 SYNONYM: LACTOSE-BINDING LECTIN 4, L-36 LACTOSE BINDING PROTEIN, COMPND 6 L36LBP, ANTIGEN NY-CO-27; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS4; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P040607-12; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS GAL-BIND LECTIN, GALECTIN, SUGAR BINDING, STRUCTURAL GENOMICS, KEYWDS 2 NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, KEYWDS 4 SUGAR BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,T.KIGAWA,K.SAITO,S.KOSHIBA,M.INOUE,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 02-MAR-22 1X50 1 REMARK SEQADV REVDAT 2 24-FEB-09 1X50 1 VERSN REVDAT 1 15-NOV-05 1X50 0 JRNL AUTH T.TOMIZAWA,T.KIGAWA,K.SAITO,S.KOSHIBA,M.INOUE,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE C-TERMINAL GAL-BIND LECTIN DOMAIN JRNL TITL 2 FROM HUMAN GALECTIN-4 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 2.6, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1X50 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000024386. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.20MM GAL-BINDING LECTIN U-15N, REMARK 210 13C; 20MM D-TRIS-HCL; 100MM NACL; REMARK 210 1MM D-DTT; 0.02% NAN3; 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9295, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 15 -176.57 -69.72 REMARK 500 1 MET A 17 43.53 -98.76 REMARK 500 1 SER A 64 -71.54 -68.50 REMARK 500 1 SER A 65 -71.34 -83.70 REMARK 500 1 ASN A 88 102.14 -41.10 REMARK 500 1 LYS A 97 105.87 -171.89 REMARK 500 1 PHE A 103 108.65 -35.33 REMARK 500 1 ARG A 119 -178.20 -173.50 REMARK 500 1 HIS A 128 95.71 -57.79 REMARK 500 1 HIS A 134 98.80 -62.40 REMARK 500 1 VAL A 142 104.72 -50.30 REMARK 500 2 PRO A 15 -164.91 -69.77 REMARK 500 2 PRO A 21 -175.37 -69.74 REMARK 500 2 LEU A 37 107.14 -54.81 REMARK 500 2 TYR A 48 117.04 -170.20 REMARK 500 2 SER A 64 -72.86 -66.47 REMARK 500 2 SER A 65 -74.68 -79.34 REMARK 500 2 ASN A 88 101.67 -38.28 REMARK 500 2 LYS A 97 105.95 -171.54 REMARK 500 2 PHE A 103 108.41 -41.01 REMARK 500 2 VAL A 142 106.93 -41.24 REMARK 500 3 SER A 3 107.08 -174.16 REMARK 500 3 HIS A 8 81.55 -59.51 REMARK 500 3 MET A 17 31.05 -96.86 REMARK 500 3 PRO A 26 -176.93 -69.69 REMARK 500 3 LEU A 37 100.00 -52.43 REMARK 500 3 LYS A 54 -64.56 -133.75 REMARK 500 3 SER A 64 -71.81 -67.15 REMARK 500 3 ASN A 88 101.59 -38.42 REMARK 500 3 LYS A 97 108.37 -175.79 REMARK 500 3 HIS A 128 101.53 -51.58 REMARK 500 3 VAL A 142 104.35 -46.52 REMARK 500 4 ASN A 12 -64.28 -108.59 REMARK 500 4 PRO A 15 -163.67 -69.78 REMARK 500 4 PRO A 21 -179.62 -69.80 REMARK 500 4 LEU A 37 106.48 -50.85 REMARK 500 4 ARG A 40 43.61 -105.03 REMARK 500 4 SER A 64 -75.26 -70.22 REMARK 500 4 SER A 65 -71.93 -77.64 REMARK 500 4 ASN A 88 102.23 -41.08 REMARK 500 4 LYS A 97 106.52 -170.58 REMARK 500 4 PHE A 103 109.72 -41.51 REMARK 500 4 HIS A 128 101.43 -55.46 REMARK 500 4 HIS A 134 104.62 -58.72 REMARK 500 4 VAL A 142 102.92 -49.23 REMARK 500 5 LEU A 14 155.95 -38.54 REMARK 500 5 PRO A 15 -170.70 -69.78 REMARK 500 5 PRO A 26 -178.43 -69.76 REMARK 500 5 GLN A 34 99.74 -64.83 REMARK 500 5 SER A 64 -72.33 -62.26 REMARK 500 REMARK 500 THIS ENTRY HAS 286 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001002278.1 RELATED DB: TARGETDB DBREF 1X50 A 8 158 UNP P56470 LEG4_HUMAN 173 323 SEQADV 1X50 GLY A 1 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 2 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 3 UNP P56470 CLONING ARTIFACT SEQADV 1X50 GLY A 4 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 5 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 6 UNP P56470 CLONING ARTIFACT SEQADV 1X50 GLY A 7 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 159 UNP P56470 CLONING ARTIFACT SEQADV 1X50 GLY A 160 UNP P56470 CLONING ARTIFACT SEQADV 1X50 PRO A 161 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 162 UNP P56470 CLONING ARTIFACT SEQADV 1X50 SER A 163 UNP P56470 CLONING ARTIFACT SEQADV 1X50 GLY A 164 UNP P56470 CLONING ARTIFACT SEQRES 1 A 164 GLY SER SER GLY SER SER GLY HIS GLN GLN LEU ASN SER SEQRES 2 A 164 LEU PRO THR MET GLU GLY PRO PRO THR PHE ASN PRO PRO SEQRES 3 A 164 VAL PRO TYR PHE GLY ARG LEU GLN GLY GLY LEU THR ALA SEQRES 4 A 164 ARG ARG THR ILE ILE ILE LYS GLY TYR VAL PRO PRO THR SEQRES 5 A 164 GLY LYS SER PHE ALA ILE ASN PHE LYS VAL GLY SER SER SEQRES 6 A 164 GLY ASP ILE ALA LEU HIS ILE ASN PRO ARG MET GLY ASN SEQRES 7 A 164 GLY THR VAL VAL ARG ASN SER LEU LEU ASN GLY SER TRP SEQRES 8 A 164 GLY SER GLU GLU LYS LYS ILE THR HIS ASN PRO PHE GLY SEQRES 9 A 164 PRO GLY GLN PHE PHE ASP LEU SER ILE ARG CYS GLY LEU SEQRES 10 A 164 ASP ARG PHE LYS VAL TYR ALA ASN GLY GLN HIS LEU PHE SEQRES 11 A 164 ASP PHE ALA HIS ARG LEU SER ALA PHE GLN ARG VAL ASP SEQRES 12 A 164 THR LEU GLU ILE GLN GLY ASP VAL THR LEU SER TYR VAL SEQRES 13 A 164 GLN ILE SER GLY PRO SER SER GLY HELIX 1 1 ALA A 138 VAL A 142 5 5 SHEET 1 A 6 THR A 22 PHE A 23 0 SHEET 2 A 6 THR A 152 SER A 159 -1 O VAL A 156 N THR A 22 SHEET 3 A 6 ARG A 41 TYR A 48 -1 N LYS A 46 O SER A 154 SHEET 4 A 6 PHE A 108 CYS A 115 -1 O LEU A 111 N ILE A 45 SHEET 5 A 6 ARG A 119 ALA A 124 -1 O TYR A 123 N SER A 112 SHEET 6 A 6 HIS A 128 ALA A 133 -1 O PHE A 130 N VAL A 122 SHEET 1 B 6 TYR A 29 ARG A 32 0 SHEET 2 B 6 THR A 144 GLY A 149 -1 O LEU A 145 N GLY A 31 SHEET 3 B 6 PHE A 56 LYS A 61 -1 N ASN A 59 O GLU A 146 SHEET 4 B 6 LEU A 70 ASN A 73 -1 O ILE A 72 N ILE A 58 SHEET 5 B 6 VAL A 82 ASN A 84 -1 O ASN A 84 N HIS A 71 SHEET 6 B 6 GLU A 95 LYS A 96 -1 O GLU A 95 N ARG A 83 SHEET 1 C 2 LEU A 86 LEU A 87 0 SHEET 2 C 2 SER A 90 TRP A 91 -1 O SER A 90 N LEU A 87 CISPEP 1 VAL A 27 PRO A 28 1 -0.08 CISPEP 2 VAL A 27 PRO A 28 2 -0.07 CISPEP 3 VAL A 27 PRO A 28 3 0.01 CISPEP 4 VAL A 27 PRO A 28 4 -0.08 CISPEP 5 VAL A 27 PRO A 28 5 0.01 CISPEP 6 VAL A 27 PRO A 28 6 -0.11 CISPEP 7 VAL A 27 PRO A 28 7 -0.02 CISPEP 8 VAL A 27 PRO A 28 8 -0.03 CISPEP 9 VAL A 27 PRO A 28 9 -0.07 CISPEP 10 VAL A 27 PRO A 28 10 -0.14 CISPEP 11 VAL A 27 PRO A 28 11 -0.06 CISPEP 12 VAL A 27 PRO A 28 12 -0.08 CISPEP 13 VAL A 27 PRO A 28 13 -0.03 CISPEP 14 VAL A 27 PRO A 28 14 -0.05 CISPEP 15 VAL A 27 PRO A 28 15 -0.07 CISPEP 16 VAL A 27 PRO A 28 16 -0.03 CISPEP 17 VAL A 27 PRO A 28 17 -0.06 CISPEP 18 VAL A 27 PRO A 28 18 -0.06 CISPEP 19 VAL A 27 PRO A 28 19 -0.09 CISPEP 20 VAL A 27 PRO A 28 20 -0.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1